Evidence mapPaperPMID 40986928Full record

ArticleShock (Augusta, Ga.)2026

Research on Sepsis and Metabolic Reprogramming from 1998 to 2025: A Bibliometric and Visualized Analysis.

Yipeng Fang, Aizhen Dou, Yunfei Zhang, Ying Zhang, Ying Gao, Keliang Xie

Abstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yipeng FangDepartment of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Aizhen DouDepartment of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Yunfei ZhangEditorial Department of Journal, Tianjin Hospital, Tianjin, China.
Ying ZhangDepartment of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Ying GaoDepartment of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Keliang XieDepartment of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.

Funding

the Clinical Research Program of Tianjin Medical University General Hospital 22ZYYLCCG05the Tianjin Science and Technology Innovation Talent Training Project 24JRRCRC00160the Tianjin the Belt and Road Joint Laboratory Project 24PTLYHZ00200
6 · The paper itself

Abstract

backgroundMetabolic reprogramming has emerged as a central mechanism in sepsis pathogenesis, influencing immune responses, organ dysfunction, and therapeutic outcomes. This study conducts a comprehensive bibliometric analysis to map the research landscape, identify key trends, and highlight future directions in this field.

methodsBased on the Science Citation Index Expanded database in Web of Science Core Collection database, we retrieved and analyzed 672 English-language original research articles and reviews. Using R-bibliometrix, VOSviewer, and CiteSpace, we performed a multidimensional analysis of academic output trends, geographical distribution, institutional and author collaboration networks, burst detection, and the evolution of research hotspots.

resultsThe analysis reveals a consistent upward trend in both publication output and citation frequency within this research domain. The United States (24.3% of total publications) and China (23.4%) have emerged as the most productive contributing nations. Notably, the United States maintains superior academic influence as evidenced by its highest citation frequency. Among institutions, Wake Forest University in the United States holds a preeminent position, having published 54 high-impact articles in this field. The journals Frontiers in Immunology , Shock , and Critical Care represent the premier academic platforms in this research domain. Immunometabolism, mitochondrial regulation, gut microbiota imbalance, and epigenetic modifications, along with the mammalian target of rapamycin/AMP-activated protein kinase/hypoxia-inducible factor 1-alpha axis and the Sirtuin family pathway, have been identified as the key research hotspots. Novel therapeutic approaches targeting metabolic regulation are rapidly emerging, including pharmacological agents, natural compounds, stem cell-based therapies, and noncoding RNA interventions.

conclusionResearch on metabolic reprogramming in sepsis shows promising prospects, with investigations into key mechanisms focusing on current research hotspots and the development of metabolism-targeted interventions emerging as critical priorities for future sepsis prevention and treatment strategies.

Indexed as

BibliometricsSepsisAnimalsHumansMetabolic ReprogrammingGlycolysisgut microbiotaimmunometabolismlactylationmacrophagemitochondria

Identifiers

PMID40986928
PMCPMC13384386

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.